Insights: DrugPatentWatch - Find Your Next Blockbuster

A paper presented at the 2nd International Conference on Systems Medicine, AI, and Drug Repurposing proposes a novel approach to […]

Source

A recent study published in JAMA Health Forum sheds light on the impact of biosimilar competition on patient out-of-pocket (OOP) […]

Source

A recent article in Communications of the ACM explores opportunities for “Permissionless innovation” in pharmaceuticals. “Permissionless innovation” refers to the […]

Source

LACTOSE-Free Medicines, 2024 is part of DrugPatentWatch’s deep library of business intelligence on biopharmaceutical drugs. Buy Lactose-Free Medicines from Amazon This […]

Source

GELATIN-Free Medicines, 2024 is part of DrugPatentWatch’s deep library of business intelligence on biopharmaceutical drugs. Buy Gelatin-Free Medicines on Amazon This […]

Source

Switching pharmaceutical excipients, the inactive components used in drug formulations, can have significant implications for both production costs and market […]

Source

Elevate your excipient business strategies with the comprehensive Drug Excipient Business Development Reports from DrugPatentWatch. Designed for excipient manufacturers seeking […]

Source

The recent paper published in PLOS ONE presents a novel approach for efficiently retrieving a substantial number of patents related […]

Source

A recent article published in Health Affairs, delves into the Federal Trade Commission’s (FTC) concerns regarding the inclusion of improper […]

Source

A recent article published in the Journal of Cheminformatics addresses the challenge of confirming the patent status of newly developed […]

Source